SciELO - Scientific Electronic Library Online

 
vol.133 issue4Endovascular treatment of descending aorta traumaIn vitro activity of telithromycin against community acquired respiratory pathogens author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista médica de Chile

Print version ISSN 0034-9887

Abstract

DUSSAILLANT N, Gastón et al. Frequency and characteristics of aspirin resistance in Chilean cardiovascular patients. Rev. méd. Chile [online]. 2005, vol.133, n.4, pp.409-417. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872005000400003.

Background: Studies performed in Anglo-Saxon countries show that 5% of patients are resistant to the antiplatelet effects of aspirin. Aim: To assess the prevalence of aspirin resistance in a sample of Chilean cardiovascular patients and its association with clinical and laboratory characteristics. Patients and Methods: Ninety nine patients (30 women, 63±10 years) treated for stable cardiovascular diseases with aspirin 100-325 mg/day were studied. Clinical and basic coagulation variables were assessed. Platelet aggregation was studied with platelet rich plasma using three different agonists in an optical aggregometer. Aspirin resistance was defined as an aggregation 20% with arachidonic acid and an aggregation 70% with ADP or collagen. Results: Eleven patients (11.11%, 95% CI= 4.95-17.27%) complied with both criteria and were classified as aspirin resistant. Current smoking was more common in aspirin resistant patients (63.6 vs 29.6%, p=0.039). Conclusions: Aspirin resistance was found in a significant proportion of cardiovascular patients and was more common among current smokers

Keywords : Aspirin; Cardiovascular diseases; Platelet aggregation inhibitors.

        · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License